Latest stories on SNDX
A Fresh Look At Syndax Pharmaceuticals
Seeking Alpha56 · neutralgeneral
Syndax Pharmaceuticals, Inc. (SNDX) Discusses Pipeline Expansion and Next Phase of Innovation for Lead Therapies - Slideshow
Seeking Alpha55 · neutralproduct/pr
Syndax Pharmaceuticals Inc (SNDX) files 8-K
SEC 8-K50 · neutralgeneral
Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event | SNDX Stock News
StockTitan63 · neutralproduct/pr
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | SNDX Stock News
StockTitan50 · neutralgeneral
Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates?
Yahoo Top56 · neutralanalyst
Syndax Pharmaceuticals: The Duration Expansion Story Is Being Underpriced
Seeking Alpha73 · bullishproduct/pr
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
TipRanks50 · neutralgeneral
Syndax Pharmaceuticals Inc (SNDX) files 8-K
SEC 8-K50 · neutralgeneral
Syndax Pharmaceuticals, Inc. (SNDX) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
Syndax Pharmaceuticals, Inc. (SNDX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | SNDX Stock News
StockTitan50 · neutralgeneral
Syndax’s $250 Million Convertible Notes: Strategic Capital Infusion Aims to Accelerate Cancer Therapy Pipeline
MarketChameleon28 · bearishgeneral
Syndax Pharmaceuticals Prices $250 Million Convertible Senior Notes
TipRanks24 · bearishgeneral
Syndax Pharmaceuticals prices $250M senior convertible notes
Seeking Alpha28 · bearishgeneral
Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes | SNDX Stock News
StockTitan24 · bearishgeneral
Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026 | SNDX Stock News
StockTitan56 · neutralproduct/pr
Why Syndax Pharmaceuticals (SNDX) is One of the Best Small Cap Stocks to Buy for 10x Potential
Yahoo Top67 · bullishanalyst